Adding mirtazapine for treatment-resistant depression is not more effective than a single antidepressant

被引：0

|

作者：

不详

机构：

来源：

BRITISH JOURNAL OF HOSPITAL MEDICINE | 2018年 / 79卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：670 / 670

页数：1

相关论文

共 50 条

[1] Adding mirtazapine to ongoing SNRIs or SSRIs did not improve symptoms of treatment-resistant depression
Simon, Gregory E.
[J]. ANNALS OF INTERNAL MEDICINE, 2019, 170 (04) : JC20 - JC20
[2] Mirtazapine for treatment-resistant depression: a preliminary report
Wan, DDC
Kundhur, D
Solomons, K
Yatham, LN
Lam, RW
[J]. JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2003, 28 (01): : 55 - 59
[3] Mirtazapine and Bupropion Combined Treatment in Treatment-resistant Depression
Lai, Chien-Han
[J]. TZU CHI MEDICAL JOURNAL, 2009, 21 (04): : 352 - 354
[4] IS ELECTROCONVULSIVE THERAPY ANY MORE EFFECTIVE THAN SIMULATED ELECTROCONVULSIVE THERAPY IN TREATMENT-RESISTANT DEPRESSION?
Bow, Alexander
[J]. PSYCHIATRIA DANUBINA, 2018, 30 : 502 - 507
[5] Acute treatment of depression Mirtazapine and paroxetine - in combination effective than single
Angersbach, Dieter
[J]. PSYCHOPHARMAKOTHERAPIE, 2009, 16 (06): : 258 - 259
[6] Antidepressant Effects of Single and Repeated Ketamine Infusions in Treatment-Resistant Depression
Phillips, Jennifer
Norris, Sandhaya
Talbot, Jeanne
Ortiz, Abigail
Birmingham, Meagan
Blier, Pierre
[J]. BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S410 - S410
[7] In treatment-resistant depression, adding esketamine nasal spray to an oral antidepressant improved symptoms at 28
Pal, Hemraj
[J]. ANNALS OF INTERNAL MEDICINE, 2019, 171 (06) : JC33 - JC33
[8] Venlafaxine/mirtazapine-combination in treatment-resistant major depression
Ullrich, H.
Pach, J. L.
Kudling, R.
Klieser, E.
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S329 - S330
[9] EFFECTIVE APPROACHES TO TREATMENT-RESISTANT DEPRESSION
MORGAN, HE
[J]. PSYCHIATRIC ANNALS, 1987, 17 (07) : 506 - 511
[10] Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression
Amany K. Hassan
Kevin C. Farmer
Nancy C. Brahm
Barbara R. Neas
[J]. International Journal of Clinical Pharmacy, 2016, 38 : 429 - 437

← 1 2 3 4 5 →